The Marked Chart Wire · Markets
Zolgensma
FDA probes tumor risks linked to Novartis gene therapy Zolgensma
Regulators are examining cancer concerns tied to Novartis' Zolgensma after treated patients developed malignancies.
The stocks in this story
Prices from Based on Fri, Nov 6 close · Opens Mon 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
More Markets news
Nvidia
Nvidia shares enter bear market ahead of earnings
Nvidia stock has fallen below a key support level, marking a decline of more than 20 percent from its recent high. Investors are currently waiting for the company's third-quarter results.
HotCoreWeave
Market focus shifts to CoreWeave earnings and inflation data
Investors are expected to watch CoreWeave earnings and upcoming inflation reports closely during the coming week.
Broadcom
Broadcom shares hit lowest close since last August
AVGO ended trading on November 5 at its weakest level since August 2025, down nearly 40 percent from its peak.
Market Outlook
Dow futures hover as market shows signs of damage; Apple, Amazon, Microsoft strong
Dow Jones futures are trading near the open while the broader market appears damaged. Apple, Amazon, and Microsoft remain strong, but Sandisk and Micron are struggling.
Market Volatility
Low stock linkages raise concerns about upcoming volatility
The degree to which individual equates move together has dropped to an all-time low. Strategists suggest that a return to normal levels could hurt market performance.
Market Trends
Dow futures fall as Sandisk and Micron lag
Dow Jones futures declined, while Apple, Amazon, and Microsoft remained resilient. Sandisk and Micron underperformed, and Berkshire Hathaway reported lower earnings.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.